Virus demyelination

Journal of NeuroVirology

Volumn 9, Issue 2, 2003, Pages 148-164

  Fazakerley, John K ^a   Walker, Robert ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

CNS; Demyelination; Multiple sclerosis; Virus

Indexed keywords

CD8 ANTIGEN;

AGE; AUTOIMMUNE DISEASE; CELL DESTRUCTION; CENTRAL NERVOUS SYSTEM INFECTION; CHILDHOOD DISEASE; CLINICAL FEATURE; DEMYELINATING DISEASE; DEVELOPED COUNTRY; FATALITY; GENETIC SUSCEPTIBILITY; GLIA CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; JC VIRUS; MEASLES VIRUS; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; MURINE HEPATITIS CORONAVIRUS; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PERSISTENT INFECTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; SEMLIKI FOREST ALPHAVIRUS; SUBACUTE SCLEROSING PANENCEPHALITIS; SUPPRESSOR CELL; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TRANSMISSION;

ALPHAVIRUS; ANIMALIA; CORONAVIRUS; JC VIRUS; MEASLES VIRUS; MURINAE; MURINE HEPATITIS VIRUS; SEMLIKI FOREST VIRUS; THEILER VIRUS; THEILER'S ENCEPHALOMYELITIS VIRUS;

EID: 0038813687     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280390194046     Document Type: Review

References (211)

1. Adami C, Pooley J, Glomb J, Stecker E, Fazal F, Fleming JO, Baker SC (1995). Evolution of mouse hepatitis virus (MHV) during chronic infection: quasispecies nature of the persisting MHV RNA. Virology 209: 337-346.
2. Agostini HT, Ryschkewitsch CF, Mory R, Singer EJ, Stoner GL (1997). JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: increased frequency of JCV type 2 in PML. J Infect Dis 176: 1-8.
3. Allsopp TE, Fazakerley JK (2000). Altruistic cell suicide and the specialized case of the virus-infected nervous system. Trends Neurosci 23: 284-290.
4. Altintas A, Cai ZL, Pease LR, Rodriguez M (1993). Differential expression of H-2K and H-2D in the central-nervous-system of mice infected with Theilers virus. J Immunol 151: 2803-2812.
5. Amor S, Scallan MF, Morris MM, Dyson H, Fazakerley JK (1996). Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis. J Gen Virol 77: 281-291.
6. Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernan MA, Olek MJ, Hankinson SE, Hunter DJ (2001). Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286: 3083-3088.
7. Astrom KE, Mancall EL, Richardson EP Jr (1958). Progressive multifocal leukoencephalopathy. Brain 81: 93-111.
8. Aubert C, Chamorro M, Brahic M (1987). Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb Pathog 3: 319-326.
9. Azoulay-Cayla A, Syan S, Brahic M, Bureau JF (2001). Roles of the H-2D(b) and H-K(b) genes in resistance to persistent Theiler's murine encephalomyelitis virus infection of the central nervous system. J Gen Virol 82: 1043-1047.
10. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M, Schroder R, Deckert M, Schmidt S, Ravid R, Rajewsky K (2000). Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 192: 393-404.
11. Baczko K, Liebert UG, Billeter M, Cattaneo R, Budka H, ter Meulen V (1986). Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis. J Virol 59: 472-478.
12. Balluz IM, Glasgow GM, Killen HM, Mabruk MJ, Sheahan BJ, Atkins GJ (1993). Virulent and avirulent strains of Semliki Forest virus show similar cell tropism for the murine central nervous system but differ in the severity and rate of induction of cytolytic damage. Neuropathol Appl Neurobiol 19: 233-239.
13. Barac-Latas V, Suchanek G, Breitschopf H, Stuehler A, Wege H, Lassmann H (1997). Patterns of oligodendrocyte pathology in coronavirus-induced subacute demyelinating encephalomyelitis in the Lewis rat. Glia 19: 1-12.
14. Barrett PN, Koschel K, Carter M, ter Meulen V (1985). Effect of measles virus antibodies on a measles SSPE virus persistently infected C6 rat glioma cell line. J Gen Virol 66: 1411-1421.
15. Barrett PN, Sheahan BJ, Atkins GJ (1980). Isolation and preliminary characterization of Semliki Forest virus mutants with altered virulence. J Gen Virol 49: 141-147.
16. Begolka WS, Haynes LM, Olson JK, Padilla J, Neville KL, Dal Canto M, Palma J, Kim BS, Miller SD (2001). CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology. J NeuroVirol 7: 409-420.
17. Berger JR, Concha M (1995). Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J NeuroVirol 1: 5-18.
18. Bihl F, Penarossi C, Guenet JL, Brahic M, Bureau JF (1997). The shiverer mutation affects the persistence of Theiler's virus in the central nervous system. J Virol 71: 5025-5030.
19. Borrow P, Tonks P, Welsh CJR, Nash AA (1992). The role of CD8+ T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. J Gen Virol 73: 1861-1865.
20. Bouteille M, Fontaine C, Vedrenne CL, Delarue J (1965). Sur un cas d'encephalite subaigue a inclusions. Etude anatomoclinique et ultrastructurale. Rev Neurol 118: 454-458.
21. Brahic M, Stroop WG, Baringer JR (1981). Theiler's virus persists in glial cells during demyelinating disease. Cell 26: 123-128.
22. Brahic M, Bureau JK (1998). Genetics of susceptibility to Theiler's virus infection. Bioessays 20: 627-633.
23. Buchmeier MJ, Lewicki HA, Talbot PJ, Knobler RL (1984). Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 132: 261-270.
24. Bureau JF, Montagutelli X, Bihl F, Lefebvre S, Guenet JL, Brahic M (1993). Mapping loci influencing the persistence of theilers virus in the murine central-nervous-system. Nat Genet 5: 87-91.
25. Cattaneo R, Rebmann G, Baczko K, ter Meulen V, Billeter MA (1987). Altered ratios of measles virus transcripts in diseased human brains. Virology 160: 523-526.
26. Cattaneo R, Schmid A, Eschle D, Baczko K, ter Meulen V, Billeter M (1988). Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55: 255-265.
27. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M (1995). Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 92: 7440-7444.
28. Chen DS, Asanaka M, Yokomori K, Wang F, Hwang SB, Li HP, Lai MM (1995). A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc Natl Acad Sci USA 92: 12095-12099.
29. Clatch RJ, Lipton HL, Miller SD (1987). Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains. Microb Pathog 3: 327-337.
30. Clatch RJ, Melvold RW, Miller SD, Lipton HL (1985). Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity. J Immunol 135: 1408-1414.
31. Compston A, Coles A (2002). Multiple sclerosis. Lancet 359: 1221-1231.
32. Connolly JH, Allen IV, Hurwitz LJ, Millar JHD (1967). Measles virus antibody and antigen in subacute sclerosing panencephalitis. Lancet 1: 542-544.
33. Cook SD, Dowling PC (1977). A possible association between house pets and multiple sclerosis. Lancet 1: 980-982.
34. DeLaTorre JC, Rall G, Oldstone C (1993). Replication of lymphocytic choriomeningitis virus is restricted in terminally differentiated neurons. J Virol 67: 7350-7359.
35. Detels R, Brody JA, McNew J, Edgar AH (1973). Further epidemiological studies of subacute sclerosing panencephalitis. Lancet 2: 11-14.
36. Dethlefs S, Brahic M, Larsson-Sciard EL (1997). An early, abundant cytotoxic T-Lymphocyte response against Theiler's virus is critical for preventing viral persistence. J Virol 71: 8875-8878.
37. Donnelly SM, Sheahan BJ, Atkins GJ (1997). Long-term effects of Semliki Forest virus infection in the mouse central nervous system. Neuropathol Appl Neurobiol 23: 235-241.
38. Dorig RE, Marcil A, Chopra A, Richardson CD (1993). The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75: 295-305.
39. Dorries R, Watanabe R, Wege H, ter Meulen V (1987). Analysis of the intrathecal Immoral immune response in Brown Norway (BN) rats, infected with the murine coronavirus JHM. J Neuroimmunol 14: 305-316.
40. Dubois-Dalcq M, Barbosa LH, Hamilton R, Sever JL (1974). Comparison between productive and latent subacute sclerosing panencephalitis viral infection in vitro. An electron microscopic and immunoperoxidase study. Lab Invest 30: 241-250.
41. Dveksler GS, Basile AA, Cardellichio CB, Beauchemin N, Dieffenbach CW, Holmes KV (1993). Expression of MHVA59 receptor glycoproteins in susceptible and resistant strains of mice. Adv Exp Med Biol 342: 267-272.
42. Dveksler GS, Pensiero MN, Cardellichio CB, Williams RK, Jiang G, Holmes KV, Dieffenbach CW (1991). Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J Virol 65: 6881-6891.
43. Ebers GC, Bulman DE, Sadovnick AD, Paty DW, Warren S, Hader W, Murray TJ, Seland TP, Duquette P, Grey T (1986). A population-based study of multiple sclerosis in twins. N Engl J Med 315: 1638-1642.
44. Ebers GC, Sadovnick AD, Risch NJ (1995). A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 377: 150-151.
45. Ebers GC, Zabriskie JB, Kunkel HG (1979). Oligoclonal immunoglobulins in subacute sclerosing panencephalitis and multiple sclerosis: a study of idiotypic determinants. Clin Exp Immunol 35: 67-75.
46. Elsner C, Dorries K (1992). Evidence of human polyomavirus BK and JC infection in normal brain tissue. Virology 191: 72-80.
47. Erlich SS, Fleming JO, Stohlman SA, Weiner LP (1987). Experimental neuropathology of chronic demyelination induced by a JHM virus variant (DS). Arch Neurol 44: 839-842.
48. Fazakerley JK (2001). Neurovirology and developmental neurobiology. Adv Virus Res 56: 73-124.
49. Fazakerley JK, Amor S, Webb HE (1983). Reconstitution of Semliki forest virus infected mice, induces immune mediated pathological changes in the CNS. Clin Exp Immunol 52: 115-120.
50. Fazakerley JK, Parker SE, Bloom F, Buchmeier MJ (1992). The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis-virus type-4 is neuroattenuated by its reduced rate of spread in the central-nervous-system. Virology 187: 178-188.
51. Fazakerley JK, Pathak S, Scallan M, Amor S, Dyson H (1993). Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons. Virology 195: 627-637.
52. Fazakerley JK, Webb HE (1987). Semliki Forest virus-induced, immune-mediated demyelination: adoptive transfer studies and viral persistence in nude mice. J Gen Virol 68: 377-385.
53. Ferrante P, Caldarelli-Stefano R, Omodeo-Zorini E, Vago L, Boldorini R, Costanzi G (1995). PCR detection of JC virus DNA in brain tissue from patients with and without progressive multifocal leukoencephalopathy. J Med Virol 47: 219-225.
54. Field EJ, Cowshall S, Narang HK, Bell TM (1972). Viruses in multiple sclerosis? Lancet 2: 280-281.
55. Fiette L, Aubert C, Brahic M, Rossi CP (1993). Theilers virus-infection of beta-2-microglobulin-deficient mice. J Virol 67: 589-592.
56. + T suppressor cells are back to the game: Are they players in autoimmunity? Autoimmunity Reviews 1: 279-283.
57. Finke D, Brinckmann UG, ter Meulen V, Liebert UG (1995). Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J Virol 69: 5469-5474.
58. Finke D, Liebert UG (1994). CD4+ T cells are essential in overcoming experimental murine measles encephalitis. Immunology 83: 184-189.
59. Fleming JO, Adami C, Pooley J, Glomb J, Stecker E, Fazal F, Baker SC (1995). Mutations associated with viral sequences isolated from mice persistently infected with MHV-JHM. Adv Exp Med Biol 380: 591-595.
60. Fournier JG, Tardieu M, Lebon P, Robain O, Ponsot G, Rozenblatt S, Bouteille M (1985). Detection of measles virus RNA in lymphocytes from peripheral-blood and brain perivascular infiltrates of patients with subacute sclerosing panencephalitis. N Engl J Med 313: 910-915.
61. Fujinami RS, Oldstone MB (1980). Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation. J Immunol 125: 78-85.
62. Gale CR, Martyn CN (1995). Migrant studies in multiple sclerosis. Prog Neurobiol 47: 425-448.
63. Gerety SJ, Clatch RJ, Lipton HL, Goswami RG, Rundell MK (1991). Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. IV. Identification of an immunodominant T cell determinant on the N-terminal end of the VP2 capsid protein in susceptible SJL/J mice. J Immunol 146: 2401-2408.
64. Gerety SJ, Rundell MK, Dal Canto MC, Miller SD (1994). Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope. J Immunol 152: 919-929.
65. Gibson PE, Knowles WA, Hand JF, Brown DW (1993). Detection of JC virus DNA in the cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Med Virol 39: 278-281.
66. Gombold JL, Sutherland RM, Lavi E, Paterson Y, Weiss SR (1995). Mouse hepatitis virus A59-induced demyelination can occur in the absence of CD8+ T cells. Microb Pathog 18: 211-221.
67. Greenham LW, Hicks D, Smith S (1988). Detection of DNA transcripts of measles genes in multiple sclerosis brain tissue by transfection. J Neurol Sci 85: 55-65.
68. Hall WW, Lamb RA, Choppin PW (1979). Measles and subacute sclerosing panencephalitis virus protein: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc Natl Acad Sci USA 76: 2047-2051.
69. Hanninen P, Arstila P, Lang H, Salmi A, Panelius M (1980). Involvement of the central nervous system in acute, uncomplicated measles virus infection. J Clin Microbiol 11: 610-613.
70. Haspel M, Lampert P, Oldstone M (1978). Temperature sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. Proc Natl Acad Sci USA 75: 4033-4036.
71. Herndon RM, Griffin DE, McCormick U, Weiner LP (1975). Mouse hepatitis virus-induced recurrent demyelination. A preliminary report. Arch Neurol 32: 32-35.
72. Herndon RM, Price DL, Weiner LP (1977). Regeneration of oligodendroglia during recovery from demyelinating disease. Science 195: 693-694.
73. Hofman FM, Hinton DR, Baemayr J, Weil M, Merrill JE (1991). Lymphokines and immunoregulatory molecules in subacute sclerosing panencephalitis. Clin Immunol Immunopathol 58: 331-342.
74. Houtman JJ, Fleming JO (1996). Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM. J NeuroVirol 2: 101-110.
75. Ikeda K, Akiyama H, Kondo H, Arai T, Arai N, Yagishita S (1995). Numerous glial fibrillary tangles in oligodendroglia in cases of subacute sclerosing panencephalitis with neurofibrillary tangles. Neurosci Lett 194: 133-135.
76. Iwasaki Y, Koprowski H (1974). Cell to cell transmission of virus in the central nervous system. I. Subacute sclerosing panencephalitis. Lab Invest 31: 187-196.
77. Jacobsen M, Cepok S, Quak E, Happel M, Gaber R, Ziegler A, Schock S, Oertel WH, Sommer N, Hemmer B (2002). Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 125: 538-550.
78. Jeffrey M, Fraser JR, Halliday WG, Fowler N, Goodsir CM, Brown DA (1995). Early unsuspected neuron and axon terminal loss in scrapie-infected mice revealed by morphometry and immunocytochemistry. Neuropathol Appl Neurobiol 21: 41-49.
79. Jenis EH, Knieser MR, Rothouse PA, Jensen GE, Scott RM (1973). Subacute sclerosing panencephalitis. Immunoultrastructural localization of measles-virus antigen. Arch Pathol 95: 81-89.
80. Johnson RT (1983). Evidence for polyomaviruses in human neurological diseases. Prog Clin Biol Res 105: 183-190.
81. Johnson RT (1998). Viral infections of the nervous system, 2nd ed, Lippincott-Raven, Philadelphia.
82. Joseph BS, Oldstone MB (1975). Immunologic injury in measles virus infection. II. Suppression of immune injury through antigenic modulation. J Exp Med 142: 864-876.
83. Kang BS, Lyman MA, Kim BS (2002). The majority of infiltrating CD8+ T cells in the central nervous system of susceptible SJL/J mice infected with Theiler's virus are virus specific and fully functional. J Virol 76: 6577-6585.
84. Karpus WJ, Pope JG, Peterson JD, Dalcanto MC, Miller SD (1995). Inhibition of theilers-virus mediated demyelination by peripheral immune tolerance induction. J Immunol 155: 947-957.
85. Katz-Levy Y, Neville KL, Girvin AM, Vanderlugt CL, Pope JG, Tan LJ, Miller SD (1999). Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. J Clin Invest 104: 599-610.
86. Kelly WR, Blakemore WF, Jagelman S, Webb HE (1982). Demyelination induced in mice by avirulent Semliki Forest virus. II. An ultrastructural study of focal demyelination in the brain. Neuropathol Appl Neurobiol 8: 43-53.
87. Knobler RL, Lampert PW, Oldstone MB (1982). Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4. Nature 298: 279-280.
88. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H (2000). Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active, inactive and remyelinated lesions. Am J Pathol 157: 267-276.
89. Kristensson K, Norrby E (1986). Persistence of RNA viruses in the central nervous system. Annu Rev Microbiol 40: 159-184.
90. Kurtzke JF, Hyllested K, Heltberg A, Olsen A (1993). Multiple sclerosis in the Faroe Islands. 5. The occurrence of the fourth epidemic as validation of transmission. Acta Neurol Scand 88: 161-173.
91. Lampert PW, Sims JK, Kniazeff AJ (1973). Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies. Acta Neuropathol (Berl) 24: 76-85.
92. Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ (1998). Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol 160: 970-978.
93. Lane TE, Liu MT, Chen BP, Asensio VC, Samawi RM, Paoletti AD, Campbell IL, Kunkel SL, Fox HS, Buchmeier MJ (2000). A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol 74: 1415-1424.
94. Lane TE, Paoletti AD, Buchmeier MJ (1997). Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus. J Virol 71: 2202-2210.
95. Lavi E, Das SJ, Weiss SR (1999). Cellular reservoirs for coronavirus infection of the brain in beta2-microglobulin knockout mice. Pathobiology 67: 75-83.
96. Lavi E, Gilden DH, Highkin MK, Weiss SR (1984). Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. J Virol 51: 563-566.
97. Lavi E, Gilden DH, Highkin MK, Weiss SR (1986). The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation. Lab Anim Sci 36: 130-135.
98. Lavi E, Murray EM, Makino S, Stohlman SA, Lai MM, Weiss SR (1990). Determinants of coronavirus MHV pathogenesis are localized to 3′ portions of the genome as determined by ribonucleic acid-ribonucleic acid recombination. Lab Invest 62: 570-578.
99. Lavi E, Suzumura A, Hirayama M, Highkin MK, Dambach DM, Silberberg DH, Weiss SR (1987). Coronavirus mouse hepatitis virus (MHV)-A59 causes a persistent, productive infection in primary glial cell cultures. Microb Pathog 3: 79-86.
100. Lavi E, Wang Q, Gombold J, Sutherland R, Paterson Y, Weiss S (1995). Pathology of MHV-A59 infection in beta 2 microglobulin negative mice. Adv Exp Med Biol 380: 179-181.
101. Lawrence DM, Patterson CE, Gales TL, D'Orazio JL, Vaughn MM, Rall GF (2000). Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation, or extracellular virus production. J Virol 74: 1908-1918.
102. Liebert UG, Baczko K, Budka H, ter Meulen V (1986). Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencephalitis. J Gen Virol 67: 2435-2444.
103. Liebert UG, Schneider-Schaulies S, Baczko K, ter Meulen V (1990). Antibody-induced restriction of viral gene expression in measles encephalitis in rats. J Virol 64: 706-713.
104. Lin MT, Hinton DR, Parra B, Stohlman SA, Van Der Veen RC (1998a). The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis. Virology 245: 270-280.
105. Lin MT, Hinton DR, Stohlman SA (1998b). Mechanisms of viral clearance in perforin-deficient mice. Adv Exp Med Biol 440: 431-436.
106. Lin MT, Stohlman SA, Hinton DR (1997). Mouse hepaitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J Virol 71: 383-391.
107. Lipton HL (1975). Theiler's virus infection in mice. An unusual biphasic disease process leading to demyelination. Infect Immun 11: 1147-1155.
108. Lipton HL, Twaddle G, Jelachich ML (1995). The predominant virus-antigen burden is present in macrophages in theilers murine encephalomyelitis virus-induced demyelinating disease. J Virol 69: 2525-2533.
109. Liu MT, Chen BP, Oertel P, Buchmeier Mi, Armstrong D, Hamilton TA, Lane TE (2000). The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol 165: 2327-2330.
110. Liu MT, Keirstead HS, Lane TE (2001). Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J Immunol 167: 4091-4097.
111. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000). Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47: 707-717.
112. Manchester M, Rall GF (2001). Model Systems: transgenic mouse models for measles pathogenesis. Trends Microbiol 9: 19-23.
113. Matthews AE, Lavi E, Weiss SR, Paterson Y (2002). Neither B cells nor T cells are required for CNS demyelination in mice persistently infected with MHV-A59. J NeuroVirol 8: 257-264.
114. McQuaid S, Allen IV, McMahon J, Kirk J (1994). Association of measles virus with neurofibrillary tangles in subacute sclerosing panencephalitis: a combined in situ hybridization and immunocytochemical investigation. Neuropathol Appl Neurobiol 20: 103-110.
115. McQuaid S, McMahon J, Herron B, Cosby SL (1997). Apoptosis in measles virus-infected human central nervous system tissues. Neuropathol Appl Neurobiol 23: 218-224.
116. Mehta PD, Thormar H, Kulczycki J, Wisniewski HM (1994). Immune response in subacute sclerosing panencephalitis. Ann NY Acad Sci 724: 378-384.
117. Melvold RW, Jokinen DM, Knobler RL, Lipton HL (1987). Variations in genetic control of susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. J Immunol 138: 1429-1433.
118. Melvold RW, Jokinen DM, Miller SD, Dal Canto MC, Lipton HL (1990). Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol 64: 686-690.
119. Miller CA, Carrigan DR (1982). Reversible repression and activation of measles virus infection in neural cells. Proc Natl Acad Sci USA 79: 1629-1633.
120. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, KatzLevy Y, Carrizosa A, Kim BS (1997). Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 3: 1133-1136.
121. Modlin JF, Jabbour JT, Witte JJ, Halsey NA (1977). Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis. Pediatrics 59: 505-512.
122. Morris MM, Dyson H, Baker D, Harbige LS, Fazakerley JK, Amor S (1997). Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection. J Neuroimmunol 74:185-197.
123. Murphy FA (1977). Rabies pathogenesis. Arch Virol 54: 279-297.
124. Murray PD, McGavern DB, Lin X, Njenga MK, Leibowitz J, Pease LR, Rodriguez M (1998). Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J Neurosci 18: 7306-7314.
125. Murray RS, Brown B, Brian D, Cabirac GF (1992a). Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann Neurol 31: 525-533.
126. Murray RS, Cai GY, Hoel K, Zhang JY, Soike KF, Cabirac GF (1992b). Coronavirus infects and causes demyelination in primate central nervous system. Virology 188: 274-284.
127. Nagano I, Nakamura S, Yoshioka M, Kogure K (1991). Immunocytochemical analysis of the cellular infiltrate in brain lesions in subacute sclerosing panencephalitis. Neurology 41: 1639-1642.
128. Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C, Gerlier D (1993). Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67: 6025-6032.
129. Neville KL, Padilla J, Miller SD (2002). Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: implications for the treatment of MS. J Neuroimmunol 123: 18-29.
130. Ogura H, Baczko K, Rima BK, ter Meulen V (1987). Selective inhibition of translation of the mRNA coding for measles virus membrane protein at elevated temperatures. J Virol 61: 472-479.
131. Ogura H, Rima BK, Tas P, Baczko K, ter Meulen V (1988). Restricted synthesis of the fusion protein of measles virus at elevated temperatures. J Gen Virol 69: 925-929.
132. Oksenberg JR, Baranzini SE, Barcellos LF, Hauser SL (2001). Multiple sclerosis: genomic rewards. J Neuroimmunol 113: 171-184.
133. Oldstone MB (1987). Molecular mimicry and autoimmune disease. Cell 50: 819-820.
134. Oldstone MB, Buchmeier MJ (1982). Restricted expression of viral glycoprotein in cells of persistently infected mice. Nature 300: 360-362.
135. Oldstone MB, Lewicki H, Thomas D, Tishon A, Dales S, Patterson J, Manchester M, Homann D, Naniche D, Holz A (1999). Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell 98: 629-640.
136. Olerup O, Hillert J (1991). HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 38: 1-15.
137. Palma JP, Lee HG, Mohindru M, Kang BS, Dal Canto M, Miller SD, Kim BS (2001). Enhanced susceptibility to Theiler's virus-induced demyelinating disease in perforin-deficient mice. J Neuroimmunol 116: 125-135.
138. Panitch HS, Hirsch RL, Haley AS, Johnson KP (1987). Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1: 893-895.
139. Parra B, Hinton DR, Marten NW, Bergmann CC, Lin MT, Yang CS, Stohlman SA (1999). IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol 162: 1641-1647.
140. Parra B, Lin MT, Stohlman SA, Bergmann CC, Atkinson R, Hinton DR (2000). Contributions of Fas-Fas ligand interactions to the pathogenesis of mouse hepatitis virus in the central nervous system. J Virol 74: 2447-2450.
141. Parsons LM, Webb HE (1982). Blood brain barrier disturbance and immunoglobulin G levels in the cerebrospinal fluid of the mouse following peripheral infection with the demyelinating strain of Semliki Forest virus. J Neurol Sci 57: 307-318.
142. Parsons LM, Webb HE (1984). Specific immunoglobulin G in serum and cerebrospinal fluid of mice infected with the demyelinating strain of Semliki Forest virus. Microbios Lett 25: 135-140.
143. Parsons LM, Webb HE (1989). Identification of immunoglobulin-containing cells in the central nervous system of the mouse following infection with the demyelinating strain of Semliki Forest virus. Br J Exp Pathol 70: 247-255.
144. Patterson JB, Manchester M, Oldstone MB (2001). Disease model: dissecting the pathogenesis of the measles virus. Trends Mol Med 7: 85-88.
145. Paula-Barbosa MM, Cruz C (1981). Nerve cell fusion in a case of subacute sclerosing panencephalitis. Ann Neurol 9: 400-403.
146. Pearce BD, Hobbs MV, McGraw TS, Buchmeier MJ (1994). Cytoking induction during T-cell-mediated clearance of mouse hepatitis from neurons in vivo. J Virol 68: 5483-5495.
147. Perlman S, Jacobsen G, Afifi A (1989). Spread of a neurotropic murine coronavirus into the CNS via the trigeminal. and olfactory nerves. Virology 170: 556-560.
148. Perlman S, Ries D (1987). The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM. Microb Patho 3: 309-314.
149. Perron H, Garson A, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, Mallet F, Tuke PW, Voisset C, Blond JL, Lalande B, Seigneurin JM, Mandrand B, and the Collaborative Research Group on Multiple Sclerosis (1997). Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sci USA 94: 7583-7588.
150. Pewe L, Wu GF, Barnett EM, Castro RF, Perlman S (1996). Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity 5: 253-262.
151. Pope JG, Karpus WJ, Vanderlugt C, Miller SD (1996). Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theilers virus-induced demyelinating disease-evidence for a CD4(+) T-cell-mediated pathology. J Immunol 156: 4050-4058.
152. Power C, Gladden JG, Halliday W, Del Bigio MR, Nath A, Ni W, Major EO, Blanchard J, Mowat M (2000). AIDS- and non-AIDS-related PML association with distinct p53 polymorphism. Neurology 54: 743-746.
153. Pullen LC, Miller SD, Dalcanto MC, Kim BS (1993). Class-I-deficient resistant mice intracerebrally inoculated with theiler virus show an increased T-cell response to viral-antigens and susceptibility to demyelination. Eur J Immunol 23: 2287-2293.
154. Pusztai R, Gould E, Smith H (1971). Infection pattern in mice of an avirulent and virulent strain of Semliki Forest virus. Br J Exp Pathol 52: 669-677.
155. Rall GF, Manchester M, Daniels LR, Callahan EM, Belman AR, Oldstone MB (1997). A transgenic mouse model for measles virus infection of the brain. Proc Natl Acad Sci USA 94: 4659-4663.
156. Ramakrishna C, Stohlman SA, Atkinson RD, Shlomchik MJ, Bergmann CC (2002). Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. J Immunol 168: 1204-1211.
157. Redwine JM, Buchmeier MJ, Evans CF (2001). In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection. Am J Pathol 159: 1219-1224.
158. Rivera-Quinones C, McGavern D, Schmelzer JD, Hunter SF, Low PA, Rodriguez M (1998). Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat Med 4: 187-193.
159. Rodriguez M, David CS (1985). Demyelination induced by Theilers virus-influence of the H-2 haplotype. J Immunol 135: 2145-2148.
160. Rodriguez M, Dunkel AJ, Thiemann RL, Leibowitz J, Zijlstra M, Jaenisch R (1993). Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin. J Immunol 151: 266-276.
161. Rodriguez M, Leibowitz JL, Lampert PW (1983). Persistent infection of oligodendrocytes in Theiler's virus induced encephalomyelitis. Ann Neurol 13: 426-433.
162. Rossi CP, McAllister A, Tanguy M, Kagi D, Brahic M (1998). Theiler's virus infection of perforin-deficient mice. J Virol 72: 4515-4519.
163. Schmidbauer M, Budka H, Shah KV (1990). Progressive multifocal leukoencephalopathy (PML) in AIDS and in the pre-AIDS era. A neuropathological comparison using immunocytochemistry and in situ DNA hybridization for virus detection. Acta Neuropathol (Berl) 80: 375-380.
164. Schneider-Schaulies J, Niewiesk S, Schneider-Schaulies S, ter Meulen V (1999). Measles virus in the CNS: the role of viral and host factors for the establishment and maintenance of a persistent infection. J NeuroVirol 5: 613-622.
165. Schneider-Schaulies S, Liebert UG, Baczko K, Cattaneo R, Billeter M, ter Meulen V (1989). Restriction of measles virus gene expression in acute and subacute encephalitis of Lewis rats. Virology 171: 525-534.
166. Schneider-Schaulies S, Liebert UG, Segev Y, Rager-Zisman B, Wolfson M, ter Meulen V (1992). Antibody-dependent transcriptional regulation of measles virus in persistently infected neural cells. J Virol 66: 5534-5541.
167. Schneider-Schaulies S, Schneider-Schaulies J, Dunster LM, ter Meulen V (1995). Measles virus gene expression in neural cells. Curr Top Microbiol Immunol 191: 101-116.
168. Schneider-Schaulies S, Schneider-Schaulies J, Schuster A, Bayer M, Pavlovic J, ter Meulen V (1994). Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J Virol 68: 6910-6917.
169. Simas JP, Fazakerley JK (1996). The course of disease and persistence of virus in the central nervous system varies between individual CBA mice infected with the BeAn strain of Theiler's murine encephalomyelitis virus. J Gen Virol 77: 2701-2711.
170. SoiluHanninen M, Eralinna JP, Hukkanen V, Roytta M, Salmi AA, Salonen R (1994). Semliki-Forest virus infects mouse-brain endothelial-cells and causes blood-brain-barrier damage. J Virol 68: 6291-6298.
171. SoiluHanninen M, Roytta M, Salmi AA, Salonen R (1997). Semliki Forest virus infection leads to increased expression of adhesion molecules on splenic T-cells and on brain vascular endothelium. J NeuroVirol 3: 350-360.
172. Sriram S, Stratton CW, Yao S, Tharp A, Ding L, Bannan JD, Mitchell WM (1999). Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 46: 6-14.
173. Stewart JN, Mounir S, Talbot PJ (1992). Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology 191: 502-505.
174. Stohlman SA, Bergmann CC, Van Der Veen RC, Hinton DR (1995a). Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J Virol 69: 684-694.
175. Stohlman SA, Hinton DR, Cua D, Dimacali E, Sensintaffar J, Hofman FM, Tahara SM, Yao Q (1995b). Tumor necrosis factor expression during mouse hepatitis virus-induced demyelinating encephalomyelitis. J Virol 69: 5898-5903.
176. Stohlman SA, Matsushima GK, Casteel N, Weiner LP (1986). In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication. J Immunol 136: 3052-3056.
177. Stohlman SA, Weiner LP (1981). Chronic central nervous system demyelination in mice after JHM virus infection. Neurology 31: 38-44.
178. Subak-Sharpe I, Dyson H, Fazakerley JK (1993). In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection. J Virol 67: 7629-7633.
179. Suckling AJ, Pathak S, Jagelman S, Webb HE (1978). Virus associated demyelination: a model using avirulent Semliki Forest virus infection of mice. J Neurol Sci 36: 147-154.
180. Sun N, Perlman S (1995). Spread of a neurotropic coronavirus to spinal cord white matter via neurons and astrocytes. J Virol 69: 633-641.
181. Tada H, Rappaport J, Lashgari M, Amini S, Wong-Staal F, Khalili K (1990). Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci USA 87: 3479-3483.
182. Takahashi K, Goto N, Matsubara Y, Fujiwara K (1987). Postinflammatory remyelination in the spinal cord of mice infected with mouse hepatitis virus, JHM strain. Jpn J Exp Med 57: 145-151.
183. Talbot PJ, Paquette JS, Ciurli C, Antel JP, Ouellet F (1996). Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann Neurol 39: 233-240.
184. Tatsuo H, Ono N, Tanaka K, Yanagi Y (2000). SLAM (CDw150) is a cellular receptor for measles virus. Nature 406: 893-897.
185. ter Meulen V, Koprowski H, Iwasaki Y, Kackell YM, Muller D (1972). Fusion of cultured multiple-sclerosis brain cells with indicator cells: Presence of nucleocapsids and virions and isolation of parainfluenza-type virus. Lancet 2: 1-15.
186. Theiler M (1934). Spontaneous encephalomyelitis of mice-a new virus disease. Science 80: 122-123.
187. Tornatore C, Berger JR, Houff SA, Curfman B, Meyers K, Winfield D, Major EO (1992). Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann Neurol 31: 454-462.
188. Tourtellotte WW, Parker JA, Herndon RM, Cuadros CV (1968). Subacute sclerosing panencephalitis: brain immunoglobulin-G, measles antibody and albumin. Neurology 18: 117-121.
189. Tremain KE, Ikeda H (1983). Physiological deficits in the visual system of mice infected with Semliki Forest virus and their correlation with those seen in patients with demyelinating disease. Brain 106: 879-895.
190. Trottier M, Schlitt BP, Lipton HL (2002). Enhanced detection of Theiler's virus RNA copy equivalents in the mouse central nervous system by real-time RT-PCR. J Virol Methods 103: 89-99.
191. Tuittila MT, Santagati MG, Roytta M, Maatta JA, Hinkkanen AE (2000). Replicase complex genes of Semliki Forest virus confer lethal neurovirulence. J Virol 74: 4579-4589.
192. Urbanska EM, Chambers BJ, Ljunggren HG, Norrby E, Kristensson K (1997). Spread of measles virus through axonal pathways into limbic structures in the brain of TAP1 -/- mice. J Med Virol 52: 362-369.
193. van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, von Blomberg BM, Woody JN, Hartung HP, Polman CH (1996). Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47: 1531-1534.
194. van Oosten BW, Lai M, Hodgkinson S, Barkhof F, Miller DH, Moseley IF, Thompson AJ, Rudge P, McDougall A, McLeod JG, Ader HJ, Polman CH (1997). Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, doubleblind, placebo-controlled, MR-monitored phase II trial. Neurology 49: 351-357.
195. Walker DL (1978). Progressive multifocal leukoencephalopathy: An opportunistic viral infection of the central nervous system. In Handbook of Clinical Neurology. Elsevier, Amsterdam, pp. 307-329.
196. Wang FI, Hinton DR, Gilmore W, Trousdale MD, Fleming JO (1992). Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab Invest 66: 744-754.
197. Watanabe R, Wege H, ter Meulen V (1983). Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature 305: 150-153.
198. Watanabe R, Wege H, ter Meulen V (1987). Comparative analysis of coronavirus JHM-induced demyelinating encephalomyelitis in Lewis and Brown Norway rats. Lab Invest 57: 375-384.
199. Weber T, Trebst C, Frye S, Cinque P, Vago L, Sindic CJ, Schulz-Schaeffer WJ, Kretzschmar HA, Enzensberger W, Hunsmann G, Luke W (1997). Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis 176: 250-254.
200. Weber T, Weber F, Petry H, Luke W (2001). Immune response in progressive multifocal leukoencephalopathy: an overview. J NeuroVirol 7: 311-317.
201. White FA, Ishaq M, Stoner GL, Frisque RJ (1992). JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy. J Virol 66: 5726-5734.
202. Williams RK, Jiang GS, Holmes KV (1991). Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a nonfunctional homologous protein in MHV-resistant SJL/J mice. J Virol 64: 3817-3823.
203. Woyciechowska JL, Trapp BD, Patrick DH, Shekarchi IC, Leinikki PO, Sever JL, Holmes KV (1984). Acute and subacute demyelination induced by mouse hepatitis virus strain A59 in C3H mice. J Exp Pathol 1: 295-306.
204. Wu GF, Dandekar AA, Pewe L, Perlman S (2000). CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J Immunol 165: 2278-2286.
205. Wu GF, Perlman S (1999). Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus. J Virol 73: 8771-8780.
206. Wucherpfennig KW, Strominger JL (1995). Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80: 695-705.
207. Xue S, Sun N, van Rooijen N, Perlman S (1999). Depletion of blood-borne macrophages does not reduce demyelination in mice infected with a neurotropic coronavirus. J Virol 73: 6327-6334.
208. Yamaguchi K, Goto N, Kyuwa S, Hayami M, Toyoda Y (1991). Protection of mice from a lethal coronavirus infection in the central nervous system by adoptive transfer of virus-specific T cell clones. J Neuroimmunol 32: 1-9.
209. Yoshikawa Y, Yamanouchi K (1984). Effect of papaverine treatment on replication of measles virus in human neural and nonneural cells. J Virol 50: 489-496.
210. Zheng L, Calenoff MA, Dal Canto MC (2001). Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination. J Neuroimmunol 118: 256-267.
211. ZuRhein GM, Chou SM (1965). Particles resembling papovaviruses in human cerebral demyelinating disease. Science 148: 1477-1479.